Evidence map›Paper›PMID 36365047›Full record

ArticlePathogens (Basel, Switzerland)2022

Potential Epha2 Receptor Blockers Involved in Cerebral Malaria from

Mohd Sayeed Shaikh, Fahadul Islam, Parag P Gargote, Rutuja R Gaikwad, Kalpana C Dhupe, Sharuk L Khan, Falak A Siddiqui, Ganesh G Tapadiya, Syed Sarfaraz Ali, Abhijit Dey and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mohd Sayeed ShaikhShreeyash Institute of Pharmaceutical Education and Research, Aurangabad 431136, India.
Fahadul IslamDepartment of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka 1341, Bangladesh.ORCID 0000-0002-8167-8264
Parag P GargoteShreeyash Institute of Pharmaceutical Education and Research, Aurangabad 431136, India.
Rutuja R GaikwadShreeyash Institute of Pharmaceutical Education and Research, Aurangabad 431136, India.
Kalpana C DhupeShreeyash Institute of Pharmaceutical Education and Research, Aurangabad 431136, India.
Sharuk L KhanDepartment of Pharmaceutical Chemistry, N.B.S. Institute of Pharmacy, Ausa 413520, India.ORCID 0000-0001-6136-9774
Falak A SiddiquiDepartment of Pharmaceutical Chemistry, N.B.S. Institute of Pharmacy, Ausa 413520, India.
Ganesh G TapadiyaShreeyash Institute of Pharmaceutical Education and Research, Aurangabad 431136, India.ORCID 0000-0002-0437-5235
Syed Sarfaraz AliSub District Hospital Ambad, Jalna 431204, India.ORCID 0000-0002-5674-8128
Abhijit DeyDepartment of Life Sciences, Presidency University, 86/1 College Street, Kolkata 700073, India.ORCID 0000-0002-5750-0802
Talha Bin EmranDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.ORCID 0000-0003-3188-2272
BGC Trust University Bangladesh · BDDaffodil International University · BDPresidency University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral malaria (CM) is a severe manifestation of parasite infection caused by

Indexed as

cerebral malariadockingEphA2 receptorRosmarinus officinalisTaraxacum officinaleTinospora cordifolia

Identifiers

PMID36365047
PMCPMC9693644
OpenAlexW4308720015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.